A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.
Clinical trial NCT03281876 · COMPLETED
Trial details
- NCT number
- NCT03281876
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2020-03-26
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.